Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
16 August 1995Website:
http://www.integralife.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
regular market | 9 min agoDividend
Analysts recommendations
Institutional Ownership
IART Latest News
According to a health economic evaluation, Integra's DuraSeal Dural Sealant is revealed to reduce healthcare costs.
The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2024 Earnings Call Transcript November 4, 2024 8:30 AM ET Company Participants Chris Ward - IR Stuart Essig - Executive Chairman Jan De Witte - President and CEO Lea Knight - CFO Conference Call Participants Steven Lichtman - Oppenheimer Vik Chopra - Wells Fargo Ryan Zimmerman - BTIG Kristen Stewart - C.L. King Robbie Marcus - JPMorgan Matt Taylor - Jefferies Richard Newitter - Truist Securities Craig Bijou - Bank of America Securities Joanne Wuensch - Citi Chris Ward Good morning and thank you for joining the Integra LifeSciences Third Quarter 2024 Earnings Conference Call.
Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.76 per share a year ago.
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024.
A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development
PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.
PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer, will present at the Wells Fargo Healthcare conference on September 4, 2024 at 1:30pm ET.
The company published its third ESG report, underscoring its values and commitment to restoring lives The company published its third ESG report, underscoring its values and commitment to restoring lives
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
What type of business is Integra LifeSciences Holdings?
Integra LifeSciences Holdings Corporation is a technology medical company whose main activity is the development, production, and sale of surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The Codman Specialty Surgical segment specializes in surgical products, including a wide range of surgical implants and instruments. The Orthopedics and Tissue Technologies segment focuses on regenerative technologies for the treatment of acute and chronic wounds; tools for surgical tissue regeneration, including hernia repair, peripheral nerve repair and protection, and tendon repair. The company was founded in 1989, with its headquarters in Princeton, New Jersey.
What sector is Integra LifeSciences Holdings in?
Integra LifeSciences Holdings is in the Healthcare sector
What industry is Integra LifeSciences Holdings in?
Integra LifeSciences Holdings is in the Medical Devices industry
What country is Integra LifeSciences Holdings from?
Integra LifeSciences Holdings is headquartered in United States
When did Integra LifeSciences Holdings go public?
Integra LifeSciences Holdings initial public offering (IPO) was on 16 August 1995
What is Integra LifeSciences Holdings website?
https://www.integralife.com
Is Integra LifeSciences Holdings in the S&P 500?
No, Integra LifeSciences Holdings is not included in the S&P 500 index
Is Integra LifeSciences Holdings in the NASDAQ 100?
No, Integra LifeSciences Holdings is not included in the NASDAQ 100 index
Is Integra LifeSciences Holdings in the Dow Jones?
No, Integra LifeSciences Holdings is not included in the Dow Jones index
When was Integra LifeSciences Holdings the previous earnings report?
No data
When does Integra LifeSciences Holdings earnings report?
The next expected earnings date for Integra LifeSciences Holdings is 28 February 2025